FDA approves Hyrnuo, a Bayer Lung Cancer Drug

On November 19, 2025, the Food and Drug Administration granted accelerated approval to sevabertinib (Hyrnuo, Bayer HealthCare Pharmaceuticals Inc.), a kinase inhibitor, for adults with locally advanced or metastatic, non-squamous non-small cell lung cancer (NSCLC) whose tumors have HER2 (ERBB2) …

READ MORE

Bourla’s Pfizer bought cancer company Seagen for $43B while baffled researchers contend with massive uptick in cancer in young folk…

Perplexed! 🤣 “But while researchers are still working to better understand what could be driving the perplexing rise,” It’s a good thing Pfizer bought cancer company Seagen for $43 billion to take advantage of the trend🥴. https://t.co/oegNTGW5GM — Edward Dowd …

READ MORE

Johnson & Johnson ordered to pay $966 million in talc cancer case after jury finds company liable

https://nypost.com/2025/10/08/business/johnson-and-johnson-ordered-to-pay-966-million-in-mae-moore-baby-powder-cancer-lawsuit/?ut A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest trial alleging its talc products cause cancer. The family of …

READ MORE

Keto, Ivermectin, & Fenbendazole: New Cancer Treatment Protocol Gains Momentum

Keto, Ivermectin, & Fenbendazole: New Cancer Treatment Protocol Gains Momentum https://t.co/htyVJfy4qd — zerohedge (@zerohedge) September 16, 2025 https://amgreatness.com/2025/09/05/new-cancer-treatment-protocol-a-success/ In 2023, according to the US Centers for Disease Control, 613,349 Americans died of cancer. That number is projected to increase to …

READ MORE

Kill Cancer Without the Immune System

Two bacteria working in harmony show powerful antitumor effects. The approach could transform treatment for immunocompromised patients. A research team led by Professor Eijiro Miyako at the Japan Advanced Institute of Science and Technology (JAIST), working in collaboration with Daiichi …

READ MORE